Protein Biomarkers for Invasive Aspergillosis Diagnostics
Protein Biomarkers for Invasive Aspergillosis Diagnostics
批准号:
8010162
负责人:
Marta L. Feldmesser
金额:
$23.53万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-01-01 至 2011-12-31
关键词:
Adrenal Cortex HormonesAffectAllergicAllergic Bronchopulmonary AspergillosisAllergic DiseaseAnimal ModelAntibody FormationAntifungal AgentsAntigensArizonaAspergillosisAspergillus fumigatusAsthmaAwardBiochemistryBiological AssayBiological MarkersBiophysicsCarbohydratesClinicalCollaborationsCommunicable DiseasesContractsDetectionDevelopmentDiagnosisDiagnosticDiagnostic ProcedureDiagnostic testsDiseaseDisease MarkerEarly DiagnosisEnzyme-Linked Immunosorbent AssayFeverFungal AntibodiesFungal ProteinsGrowthHeadHypersensitivityImmunoassayIn VitroIndividualInfectionLinkLung diseasesMass Spectrum AnalysisMediatingMedicineMethodsModelingMolecularMonoclonal AntibodiesMusOrganismOutcomePathogenesisPatientsProcessProteinsProteomeProteomicsReagentRecombinant ProteinsResourcesSerumSpecimenSyndromeUnited States National Institutes of HealthUniversitiesassay developmentbasebiodefenseburden of illnessclinical applicationcollegedisease diagnosisflexibilityimmunosuppressedimprovedinnovationmortalitynovel diagnosticspoint of careprototyperesponse
中文摘要
描述(申请人提供):随着易感人群的增加,烟曲霉引起的疾病负担大幅增加。此外,由于诊断困难,可能严重低估了受影响的实际人数。侵袭性曲霉病患者预后的改善与早期诊断直接相关,这突显了对更准确诊断测试的需要。对诊断化验提出的挑战包括:1.有机体的无处不在,需要区分污染、感染和疾病的能力;2.易感宿主的种类,在这些宿主中,疾病的发病机制可能不同;疾病症状的谱系,范围从过敏介导的过程到曲菌球到侵袭性疾病。目前,诊断开发的大部分工作集中在血清碳水化合物抗原的检测、基于聚合酶链式反应的真菌负荷指标或用于检测抗真菌抗体反应的免疫分析。真菌蛋白质组学分析一般局限于体外生长条件。这项申请提出了一项由阿尔伯特·爱因斯坦医学院的Marta FeldMesser博士与John Galgiani博士和Vicki Wysocki博士(亚利桑那大学)的合作,以在中性粒细胞减少症和皮质类固醇治疗的小鼠的动物模型中识别与侵袭性疾病相关的特定蛋白质生物标记物,但在过敏性支气管肺曲霉菌病的模型中没有发现。将探索真菌蛋白质组的标记范围,以便使用质谱学方法识别生物标记,从而获得更敏感和特异的疾病标记。然后,重组蛋白将被用来产生可用于基于质谱学的分析开发的单抗。提出了六个具体目标:1.鉴定侵袭性肺部疾病而不是真菌性哮喘期间特异存在的烟曲霉菌蛋白;2.表达和纯化侵袭性曲霉病三个候选生物标记物的重组蛋白;3.制作针对AIM 1中鉴定的真菌蛋白的单抗用于诊断分析;4.使用质谱仪鉴定用于免疫分析的单抗;5.建立一种检测实验性侵袭性和过敏性曲霉病小鼠模型和其他NIH合同资源的临床标本中候选生物标记物的原型ELISA法;以及6.开始将重组蛋白和单抗试剂迁移到多重和护理点平台上,用于临床应用。前两个目标将在颁奖的R21部分实现,其余四个将在R33期间完成。这些研究的完成将为新的诊断方法提供潜在的灵活性,以响应特定的临床环境。
英文摘要
DESCRIPTION (provided by applicant): With the rise in susceptible individuals, the burden of disease due to Aspergillus fumigatus has increased substantially. In addition, because of the difficulties in diagnosis, the actual number of affected people likely has been severely underestimated. Improved outcome in patients with invasive aspergillosis has been directly linked to earlier diagnosis, underscoring the need for more accurate diagnostic tests. Among the challenges posed for diagnostic assays include: i. the ubiquity of the organism, necessitating the ability to distinguish between contamination, infection, and disease; ii. the variety of susceptible hosts, in whom the pathogenesis of disease may vary; iii. the spectrum of disease syndromes, which range from allergy-mediated processes to aspergilloma to invasive disease. At present, the majority of effort in diagnostic development has focused on serum detection of carbohydrate antigens, PCR-based indicators of fungal burden or immunoassays for detection of anti-fungal antibody responses. Fungal proteomic analyses generally have been limited to in vitro growth conditions. This application proposes a collaboration between Dr. Marta Feldmesser (Albert Einstein College of Medicine) with Drs. John Galgiani and Vicki Wysocki (University of Arizona) to identify specific protein biomarkers associated with invasive disease in animal models of neutropenic and corticosteroid-treated mice, but that are not found in a model of allergic bronchopulmonary aspergillosis. The fungal proteome will be probed for the range of markers that will allow for more sensitive and specific markers of disease using mass spectrometry approaches to biomarker identification. Recombinant proteins then will be used to create monoclonal antibodies that can be used for mass spectrometry-based assay development. Six specific aims are proposed: 1. To identify A. fumigatus proteins present specifically during invasive pulmonary disease and not during fungal asthma; 2. to express and purify recombinant proteins of three candidate biomarkers of invasive aspergillosis; 3. to make monoclonal antibodies to fungal proteins identified in Aim 1 for use in diagnostic assays; 4. to use mass spectrometry to identify monoclonal antibodies for use in immunoassays; 5. to develop a prototype ELISA to detect candidate biomarkers in experimental invasive and allergic aspergillosis murine models and in clinical specimens from other NIH contract resources; and 6. to begin to migrate the recombinant protein and MAb reagents to multiplex and point-of-care platforms for clinical applications. The first two Aims would be accomplished during the R21 portion of the award, while the remaining four would be done during the R33 period. The accomplishment of these studies would provide novel diagnostic methods with potential for flexibility in response to particular clinical settings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protein Biomarkers for Invasive Aspergillosis Diagnostics
-
批准号:8413661
-
项目类别:
-
资助金额:$49.13万
-
财政年份:2010
-
负责人:Marta L. Feldmesser
-
依托单位:
Protein Biomarkers for Invasive Aspergillosis Diagnostics
-
批准号:9234611
-
项目类别:
-
资助金额:$18.98万
-
财政年份:2010
-
负责人:Marta L. Feldmesser
-
依托单位:
Protein Biomarkers for Invasive Aspergillosis Diagnostics
-
批准号:7788036
-
项目类别:
-
资助金额:$21.3万
-
财政年份:2010
-
负责人:Marta L. Feldmesser
-
依托单位:
Protein Biomarkers for Invasive Aspergillosis Diagnostics
-
批准号:8434808
-
项目类别:
-
资助金额:$46.26万
-
财政年份:2010
-
负责人:Marta L. Feldmesser
-
依托单位:
Monoclonal antibodies to inhibit Aspergillus germination
-
批准号:7172337
-
项目类别:
-
资助金额:$36.27万
-
财政年份:2006
-
负责人:Marta L. Feldmesser
-
依托单位:
Monoclonal antibodies to inhibit Aspergillus germination
-
批准号:7039283
-
项目类别:
-
资助金额:$37.26万
-
财政年份:2006
-
负责人:Marta L. Feldmesser
-
依托单位:
Monoclonal antibodies to inhibit Aspergillus germination
-
批准号:7348369
-
项目类别:
-
资助金额:$39.53万
-
财政年份:2006
-
负责人:Marta L. Feldmesser
-
依托单位:
Monoclonal antibodies to inhibit Aspergillus germination
-
批准号:7544549
-
项目类别:
-
资助金额:$39.53万
-
财政年份:2006
-
负责人:Marta L. Feldmesser
-
依托单位:
Monoclonal antibodies to inhibit Aspergillus germination
-
批准号:7759644
-
项目类别:
-
资助金额:$39.14万
-
财政年份:2006
-
负责人:Marta L. Feldmesser
-
依托单位:
Aspergillosis: Engineering Antibody for Diagnosis
-
批准号:6957015
-
项目类别:
-
资助金额:$20.61万
-
财政年份:2005
-
负责人:Marta L. Feldmesser
-
依托单位:
Aspergillosis: Engineering Antibody for Diagnosis
-
批准号:7140251
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2005
-
负责人:Marta L. Feldmesser
-
依托单位:
Monoclonal antibodies for invasive aspergillosis
-
批准号:6561654
-
项目类别:
-
资助金额:$8.35万
-
财政年份:2002
-
负责人:Marta L. Feldmesser
-
依托单位:
Monoclonal antibodies for invasive aspergillosis
-
批准号:6659763
-
项目类别:
-
资助金额:$8.35万
-
财政年份:2002
-
负责人:Marta L. Feldmesser
-
依托单位:
ANTIBODY ACTION MECHANISM AGAINST CRYPTOCOCCUS NEOFORMAN
-
批准号:2886012
-
项目类别:
-
资助金额:$9.13万
-
财政年份:1996
-
负责人:Marta L. Feldmesser
-
依托单位:
ANTIBODY ACTION MECHANISM AGAINST CRYPTOCOCCUS NEOFORMAN
-
批准号:2671381
-
项目类别:
-
资助金额:$9.13万
-
财政年份:1996
-
负责人:Marta L. Feldmesser
-
依托单位:
ANTIBODY ACTION MECHANISM AGAINST CRYPTOCOCCUS NEOFORMAN
-
批准号:2057643
-
项目类别:
-
资助金额:$8.05万
-
财政年份:1996
-
负责人:Marta L. Feldmesser
-
依托单位:
ANTIBODY ACTION MECHANISM AGAINST CRYPTOCOCCUS NEOFORMAN
-
批准号:6169227
-
项目类别:
-
资助金额:$12.61万
-
财政年份:1996
-
负责人:Marta L. Feldmesser
-
依托单位:
ANTIBODY ACTION MECHANISM AGAINST CRYPTOCOCCUS NEOFORMAN
-
批准号:2457637
-
项目类别:
-
资助金额:$8.05万
-
财政年份:1996
-
负责人:Marta L. Feldmesser
-
依托单位:
海外基金